Search company, investor...
NTT Research company logo

NTT Research

About NTT Research

NTT Research, part of NTT Group (Nippon Telegraph and Telephone Corporation), is a Silicon Valley startup that conducts basic research and advances technologies that promote positive change. Currently, three labs are housed at NTT Research: the Physics and Informatics (PHI) Lab, the Cryptography and Information Security (CIS) Lab, and the Medical and Health Informatics (MEI) Lab. The organization aims to upgrade reality in three areas: 1) quantum information, neuro-science and photonics; 2) cryptographic and information security; and 3) medical and health informatics.

Headquarters Location

1950 University Ave. Suite 600

Palo Alto, California, 94303,

United States


Missing: NTT Research's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NTT Research's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing NTT Research

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NTT Research is included in 1 Expert Collection, including Semiconductors, Chips, and Advanced Electronics.


Semiconductors, Chips, and Advanced Electronics

6,168 items

Companies in this collection develop everything from microprocessors to flash memory, integrated circuits specifically for quantum computing and artificial intelligence to OLED for displays, massive production fabs to circuit design firms, and everything in between.

NTT Research Patents

NTT Research has filed 1 patent.

The 3 most popular patent topics include:

  • Computer security
  • Cybercrime
  • Cyberwarfare
patents chart

Application Date

Grant Date


Related Topics




Computer security, People associated with computer security, Cyberwarfare, Hacking (computer security), Cybercrime


Application Date


Grant Date



Related Topics

Computer security, People associated with computer security, Cyberwarfare, Hacking (computer security), Cybercrime



Latest NTT Research News

NTT Research and Harvard Collaborate on Cardiovascular Bio Digital Twin

Nov 17, 2022

Joint Research to Focus on Building Models; MEI Lab also Hires New Research Scientist NTT Research , Inc., a division of NTT announced that its Medical & Health Informatics (MEI) Lab has entered a three-year joint research agreement with the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS). NTT Research scientists will work with the Disease Biophysics Group (DBG) at SEAS to engineer a model of the human heart, elucidate fundamental laws of muscular pumps, and apply lessons learned to a cardiovascular (CV) bio digital twin model. The agreement commenced on July 1, 2022. The principal investigator of the research project is Harvard Professor Kevin Kit Parker, who leads DBG, an interdisciplinary team with significant experience building micro-physiological systems to approximate the physiology and pathophysiology of the human heart. The directing investigator at NTT Research is Dr. Tetsuhiko Teshima, a research scientist at the MEI Lab and visiting researcher in the Neuroelectrical Group within the Munich School of BioEngineering at the Technical University of Munich (TUM). NTT Research has also added a new research scientist to the MEI Lab staff, Mr. Ryoma Ishii, an expert in organ-on-chip science and technology, who is also a visiting scientist at Harvard and will be serving as another investigator on the project, along with MEI Lab Director Joe Alexander, M.D., Ph.D. @NttResearch’s Medical & Health Informatics Lab joined a research agreement with @hseas. This partnership will move researchers closer to engineering a model of the human heart and apply lessons to the cardiovascular bio digital twin model. #UpgradeReality “We respect Dr. Parker’s work at Harvard and are thrilled to get this research underway,” Dr. Alexander said. “His group’s long-term goal of engineering a living, functional heart maps well with our CV bio digital twin initiative. Together, we hope to investigate and challenge tenets of cardiac physiology that may be based more on lore than experimental verification.” The project builds upon advances in bioengineering and the two organization’s overlapping strategic goals. Micro-physiological systems, or organs on chips, have given scientists at Harvard’s DBG an in vitro method of testing therapeutics in cells reprogrammed to an embryonic-like pluripotent state that recapitulates a disease of interest. In its nearly two decades of working toward the goal of engineering a human heart, the DBG has found ways to use human stem cell-derived cardiac myocytes to understand how to build muscular pumps and their fundamental design laws. For its part, the MEI Lab has developed bioelectrodes as the interfaces with cells and tissues to accelerate the development of an in vitro CV bio digital twin. The joint research promises to elucidate structure-function relationships of the heart that may have been overlooked in the canon of CV physiology. “There needs to be a strong relationship between people building models, like the MEI Lab, and the organs-on-chip people, like ourselves,” Dr. Parker said. “This joint research project will help ensure a productive interchange between experimental design, the parameter values that we generate and the development of the CV bio digital twin model.” A key player in this project will be MEI Lab Research Scientist Ryoma Ishii , who joined NTT Research in June 2022 and has been a visiting scientist at Harvard since December 2019. Mr. Ishii obtained his BS and MS degrees in Chemistry, with distinction, from the University of Tokyo, has worked as a bioengineering researcher and chemist at Sekisui Chemical Co., and served as a visiting scientist at Kyoto University. Early projects of note include work on a microfluidic chip for influenza diagnosis and a chemically defined, induced pluripotent stem-cell (iPS) scaffold for mass production. At Harvard, he has conducted organ-on-a-chip research, combining a microfluidic chip and cell analysis system. In his joint Harvard and NTT Research roles, he is collecting electrophysiological data of in vitro heart models, screening a suitable polymer for the surface of electrodes to measure the electrophysiology of the models and supporting the joint research project in other ways. “I am honored to be joining the MEI Lab team at NTT Research while continuing complementary work at Harvard,” Mr. Ishii said. “My motivating dream has been to revolutionize healthcare worldwide through regenerative and preventative medicine, and the ambitious research of these two distinguished research organizations align perfectly with that personal goal.” In addition to this agreement with Harvard, the MEI Lab has undertaken joint research with the Neuroelectrical Group at the Technical University of Munich and the National Cerebral and Cardiovascular Center (NCVC) in Osaka, Japan. The MEI Lab’s ongoing research includes work on multi-scale precision cardiology platforms and heart-on-a-chip technology, aimed at developing the infrastructure for a digital replica of an individual’s heart. This collaboration with Harvard also expands upon NTT Research’s joint research with the university. Earlier this year, NTT Research’s Physics & Informatics (PHI) Lab announced a joint research agreement with scientists at Harvard University to study animal neuro-responses with the hope of informing future artificial intelligence systems.

NTT Research Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NTT Research Rank

NTT Research Frequently Asked Questions (FAQ)

  • Where is NTT Research's headquarters?

    NTT Research's headquarters is located at 1950 University Ave., Palo Alto.

  • Who are NTT Research's competitors?

    Competitors of NTT Research include Biotwin.

Compare NTT Research to Competitors

iCarbonX Logo

iCarbonX is developing an artificial intelligence platform to facilitate research related to the treatment of diseases, preventive care and precision nutrition. This approach is considered as an essential element to enable the future development of personalized medicine.

Q Bio Logo
Q Bio

Q Bio builds technology that quantifies, digitizes, and simulates human physiology.

Molecular You

Molecular You analyzes a range of biomarkers to show health risks and what the user can do about it. Its preventive health assessment analyze not only genetics, but also metabolites, proteins, nutrients, and toxins to give the user the full picture. Then, it designs a personal diet and fitness plan to help the user stay healthy.

Biotwin Logo

Biotwin empowers health professionals with data-driven and technological solutions to help them make better decisions and recommendations

Philips Logo

Philips (NYSE:PHG) is a diversified technology company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle, and Lighting. The company provides cardiac care, acute care and home healthcare, energy efficient lighting solutions, and new lighting applications, as well as male shaving and grooming and oral healthcare.

Philips Lifeline

Philips Lifeline offers the Lifeline Personal Emergency Response System (PERS), senior living solutions with 24/7 access to trained care specialists, and digital solutions that help caregivers stay connected and coordinate their loved one's needs.On May 5th, 2021, Philips Lifeline was acquired by Connect America. The terms of the transaction were not disclosed.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.